• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epigenetics within the matrix: a neo-regulator of fibrotic disease.基质中的表观遗传学:纤维化疾病的新型调节剂。
Epigenetics. 2012 Sep;7(9):987-93. doi: 10.4161/epi.21567. Epub 2012 Aug 16.
2
DNA methylation regulated gene expression in organ fibrosis.DNA 甲基化调控器官纤维化中的基因表达。
Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2389-2397. doi: 10.1016/j.bbadis.2017.05.010. Epub 2017 May 10.
3
Epigenetic regulation of cardiac fibrosis.心脏纤维化的表观遗传调控。
Cell Signal. 2013 Sep;25(9):1932-8. doi: 10.1016/j.cellsig.2013.03.024. Epub 2013 Apr 16.
4
Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification.心脏纤维化中的表观遗传学特征,特别强调 DNA 甲基化和组蛋白修饰。
Heart Fail Rev. 2018 Sep;23(5):789-799. doi: 10.1007/s10741-018-9694-z.
5
Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.表观遗传机制:在系统性硬化症发病机制中的新作用及其治疗潜力
Int J Biochem Cell Biol. 2015 Oct;67:92-100. doi: 10.1016/j.biocel.2015.05.023. Epub 2015 Jun 1.
6
Epigenetic regulation of wound healing and fibrosis.创伤愈合和纤维化的表观遗传调控。
Curr Opin Rheumatol. 2013 Jan;25(1):101-7. doi: 10.1097/BOR.0b013e32835b13e1.
7
Targeting chromatin dysregulation in organ fibrosis.靶向器官纤维化中的染色质失调。
Cytokine Growth Factor Rev. 2021 Feb;57:64-72. doi: 10.1016/j.cytogfr.2020.08.004. Epub 2020 Aug 30.
8
Epigenetics as a versatile regulator of fibrosis.表观遗传学作为纤维化的多功能调节剂。
J Transl Med. 2023 Mar 2;21(1):164. doi: 10.1186/s12967-023-04018-5.
9
Epigenetic modifications in fibrotic diseases: implications for pathogenesis and pharmacological targets.纤维化疾病中的表观遗传修饰:对发病机制和药物靶点的影响。
J Pharmacol Exp Ther. 2015 Jan;352(1):2-13. doi: 10.1124/jpet.114.219816. Epub 2014 Oct 31.
10
EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs.EP300 作为纤维化转录程序的分子整合因子。
Int J Mol Sci. 2023 Aug 1;24(15):12302. doi: 10.3390/ijms241512302.

引用本文的文献

1
Genetics, sex and the use of platelet-rich plasma influence the development of arthrofibrosis after anterior cruciate ligament reconstruction.遗传学、性别以及富血小板血浆的使用会影响前交叉韧带重建术后关节纤维化的发展。
J Exp Orthop. 2025 Jan 28;12(1):e70156. doi: 10.1002/jeo2.70156. eCollection 2025 Jan.
2
Pluripotent epigenetic regulator OBP-801 maintains filtering blebs in glaucoma filtration surgery model.多能表观遗传调节剂 OBP-801 维持青光眼过滤手术模型中的滤过泡。
Sci Rep. 2020 Dec 1;10(1):20936. doi: 10.1038/s41598-020-77811-7.
3
A new nucleosomic-based model to identify and diagnose SSc-ILD.一种基于核小体的新型模型,用于识别和诊断 SSc-ILD。
Clin Epigenetics. 2020 Aug 17;12(1):124. doi: 10.1186/s13148-020-00915-4.
4
Adaptive and innate immune mechanisms in cardiac fibrosis complicating pulmonary arterial hypertension.心脏纤维化合并肺动脉高压中的适应性和固有免疫机制。
Physiol Rep. 2020 Aug;8(15):e14532. doi: 10.14814/phy2.14532.
5
Identification of Differentially Methylated CpG Sites in Fibroblasts from Keloid Scars.瘢痕疙瘩成纤维细胞中差异甲基化CpG位点的鉴定
Biomedicines. 2020 Jun 28;8(7):181. doi: 10.3390/biomedicines8070181.
6
Endoplasmic Reticulum Stress in Subepithelial Myofibroblasts Increases the TGF-β1 Activity That Regulates Fibrosis in Crohn's Disease.上皮下肌成纤维细胞中的内质网应激增加了 TGF-β1 活性,从而调节克罗恩病中的纤维化。
Inflamm Bowel Dis. 2020 May 12;26(6):809-819. doi: 10.1093/ibd/izaa015.
7
Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis.特发性肺纤维化患者循环核小体中表观遗传特征的改变
Clin Epigenetics. 2017 Aug 15;9:84. doi: 10.1186/s13148-017-0383-x. eCollection 2017.
8
A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis.功能失调性伤口愈合在特发性肺纤维化发病机制及治疗中作用的系统评价
J Clin Med. 2016 Dec 26;6(1):2. doi: 10.3390/jcm6010002.
9
Myofibroblast secretome and its auto-/paracrine signaling.肌成纤维细胞分泌组及其自分泌/旁分泌信号传导。
Expert Rev Cardiovasc Ther. 2016;14(5):591-8. doi: 10.1586/14779072.2016.1147348. Epub 2016 Feb 17.
10
Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells.纯化的、未培养的人肝细胞和活化肝星状细胞中DNA甲基化和基因表达模式的全基因组分析。
Oncotarget. 2015 Sep 29;6(29):26729-45. doi: 10.18632/oncotarget.4925.

本文引用的文献

1
Altered DNA methylation profile in idiopathic pulmonary fibrosis.特发性肺纤维化中的 DNA 甲基化谱改变。
Am J Respir Crit Care Med. 2012 Sep 15;186(6):525-35. doi: 10.1164/rccm.201201-0077OC. Epub 2012 Jun 14.
2
TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex.TGF-β 依赖性活性去甲基化和 p15ink4b 肿瘤抑制因子的表达被 ZNF217/CoREST 复合物所损害。
Mol Cell. 2012 Jun 8;46(5):636-49. doi: 10.1016/j.molcel.2012.03.027. Epub 2012 May 3.
3
Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation.组蛋白甲基转移酶 ASH1 在肌成纤维细胞转分化过程中协调纤维化基因转录。
Hepatology. 2012 Sep;56(3):1129-39. doi: 10.1002/hep.25754.
4
Global analysis of DNA methylation in early-stage liver fibrosis.早期肝纤维化中 DNA 甲基化的全局分析。
BMC Med Genomics. 2012 Jan 27;5:5. doi: 10.1186/1755-8794-5-5.
5
Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis.螺旋缩酮 A 抑制肺纤维化患者成纤维细胞的增殖和分化。
Am J Respir Cell Mol Biol. 2012 May;46(5):687-94. doi: 10.1165/rcmb.2011-0040OC. Epub 2012 Jan 12.
6
Regulation of a disintegrin and metalloprotease-33 expression by transforming growth factor-β.转化生长因子-β对解整合素金属蛋白酶-33表达的调控。
Am J Respir Cell Mol Biol. 2012 May;46(5):633-40. doi: 10.1165/rcmb.2011-0030OC. Epub 2012 Jan 6.
7
MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats.MeCP2 控制着大鼠肝纤维化中 RASAL1 的表达。
Toxicology. 2011 Dec 18;290(2-3):327-33. doi: 10.1016/j.tox.2011.10.011. Epub 2011 Oct 25.
8
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.TGF-β 调节前列腺癌中的 DNA 甲基转移酶表达,与侵袭能力相关,并可预测疾病复发。
PLoS One. 2011;6(9):e25168. doi: 10.1371/journal.pone.0025168. Epub 2011 Sep 30.
9
Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition.HDAC3 和 WDR5 之间的相互作用对于缺氧诱导的上皮-间充质转化至关重要。
Mol Cell. 2011 Sep 2;43(5):811-22. doi: 10.1016/j.molcel.2011.07.012.
10
Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.组蛋白 3 赖氨酸 9(H3K9)甲基转移酶被招募到白细胞介素 2(IL-2)启动子是转化生长因子-β-Smad 途径抑制 IL-2 转录的机制。
J Biol Chem. 2011 Oct 14;286(41):35456-35465. doi: 10.1074/jbc.M111.236794. Epub 2011 Aug 23.

基质中的表观遗传学:纤维化疾病的新型调节剂。

Epigenetics within the matrix: a neo-regulator of fibrotic disease.

机构信息

The Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.

出版信息

Epigenetics. 2012 Sep;7(9):987-93. doi: 10.4161/epi.21567. Epub 2012 Aug 16.

DOI:10.4161/epi.21567
PMID:22894907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3515019/
Abstract

Fibrosis of any tissue is characterized by excessive extracellular matrix accumulation that ultimately destroys tissue architecture and eventually abolishes normal organ function. Although much research has focused on the mechanisms underlying disease pathogenesis, there are still no effective antifibrotic therapies that can reverse, stop or delay the formation of scar tissue in most fibrotic organs. As fibrosis can be described as an aberrant wound healing response, a recent hypothesis suggests that the cells involved in this process gain an altered heritable phenotype that promotes excessive fibrotic tissue accumulation. This article will review the most recent observations in a newly emerging field that links epigenetic modifications to the pathogenesis of fibrosis. Specifically, the roles of DNA methylation and histone modifications in fibrotic disease will be discussed.

摘要

任何组织的纤维化都以细胞外基质的过度积累为特征,最终破坏组织的结构,并最终导致正常器官功能的丧失。尽管许多研究都集中在疾病发病机制的机制上,但目前仍然没有有效的抗纤维化疗法可以逆转、阻止或延缓大多数纤维化器官中瘢痕组织的形成。由于纤维化可以被描述为异常的伤口愈合反应,最近的一个假说表明,参与这个过程的细胞获得了一种改变的可遗传表型,从而促进了过多的纤维化组织的积累。本文将综述这一新兴领域的最新观察结果,该领域将表观遗传修饰与纤维化的发病机制联系起来。具体来说,将讨论 DNA 甲基化和组蛋白修饰在纤维化疾病中的作用。